Helping EGFR inhibition to block cancer
Effectiveness of EGFR treatment is impaired through an early adaptive response. TNF-JNK-Axl-ERK signaling contributes to this primary resistance to EGFR inhibition and might serve as novel target to improve EGFR inhibition.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
26 July 2017
|
| In: |
Nature neuroscience
Year: 2017, Volume: 20, Issue: 8, Pages: 1035-1037 |
| ISSN: | 1546-1726 |
| DOI: | 10.1038/nn.4605 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1038/nn.4605 Verlag, Volltext: https://www.nature.com/articles/nn.4605 
|
| Author Notes: | Rolf Warta & Christel Herold-Mende |
| Summary: | Effectiveness of EGFR treatment is impaired through an early adaptive response. TNF-JNK-Axl-ERK signaling contributes to this primary resistance to EGFR inhibition and might serve as novel target to improve EGFR inhibition. |
|---|---|
| Item Description: | Gesehen am 28.11.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1546-1726 |
| DOI: | 10.1038/nn.4605 |